Labcorp Holdings (LH) closed at $366.57 on November 6, 2026, up 0.9% from the previous close, on volume of 514,683 shares (30-day average 701,506).
Data as of November 6, 2026.
6-Nov-2026
| # | Date | Strategy | Legs | Contracts |
|---|---|---|---|---|
| 1 | Oct 26, 2026 | Seagull With Put Spread | 20-Nov-26290 P : 320 P : 360 C | 750 |
| 2-2 | The next 1 largest trades are for Premium members. Start a 7-day free trial | |||
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 6, 2026. See the 10 largest for 30, 60 and 90 days
Labcorp raised to Buy at HSBC on M&A and diagnostics momentum
Seeking Alpha News (Thu, 5-Nov 10:10 AM ET)
Labcorp Announces CFO Participation in UBS Healthcare Conference
TipRanks (Wed, 4-Nov 9:50 AM ET)
Labcorp to Speak at the UBS Global Healthcare Conference
PRNewswire (Wed, 4-Nov 8:00 AM ET)
Labcorp Reports Strong 2026 Third Quarter Results; Raises Full Year 2026 Guidance
PRNewswire (Wed, 28-Oct 6:51 AM ET)
PRNewswire (Fri, 23-Oct 8:00 AM ET)
PRNewswire (Thu, 22-Oct 4:30 PM ET)
Labcorp Declares Quarterly Dividend
PRNewswire (Wed, 21-Oct 6:50 AM ET)
Globe Newswire (Tue, 20-Oct 8:30 AM ET)
Labcorp Enters into Agreement with OPKO Health to Acquire Select Assets of BioReference Health
PRNewswire (Thu, 15-Oct 7:30 AM ET)
Labcorp and Arianna Huffington's Thrive Global Collaborate to Launch Thrive 5 Health Test
PRNewswire (Tue, 13-Oct 8:01 AM ET)
Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from uncomplicated routine blood and urine screens to complex oncology and genomic testing.
Labcorp Holdings trades on the NYSE stock market under the symbol LH.
As of November 6, 2026, LH stock price climbed to $366.57 with 514,683 million shares trading.
LH has a beta of 0.01, meaning it tends to be less sensitive to market movements. LH has a correlation of 0.00 to the broad based SPY ETF.
LH has a market cap of $29.77 billion. This is considered a Large Cap stock.
Last quarter Labcorp Holdings reported $4 billion in Revenue and $4.78 earnings per share. This beat revenue expectation by $49 million and exceeded earnings estimates by $.14.
In the last 3 years, LH traded as high as $373.34 and as low as $191.97.
The top ETF exchange traded funds that LH belongs to (by Net Assets): VTI, VOO, VO, IVV, SPY.
LH has outperformed the market in the last year with a price return of +49.8% while the SPY ETF gained +10.8%. LH has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +16.0% and +11.4%, respectively, while the SPY returned -4.1% and -3.2%, respectively.
LH support price is $355.83 and resistance is $370.77 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that LH shares will trade within this expected range on the day.
